Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: We investigated the effect of subclinical hyperthyroidism and subclinical hypothyroidism on cognitive function in rats and the role of autophagy in this process.

Methods: Forty Wistar rats were randomized into normal control (NC), hyperthyroidism (Hyper), hypothyroidism (Hypo), subclinical hyperthyroidism (sHyper), and subclinical hypothyroidism (sHypo) groups. Cognitive function (spatial learning and memory) was tested by the Morris water maze test. Hippocampal histopathology was analyzed by H&E staining, and expression levels of caspase-3 in hippocampal CA1 neurons were measured. In addition, immunoblot analysis was performed to detect hippocampal autophagy-related proteins.

Results: Escape latency from day 1 to day 4 was significantly longer in the Hypo, Hyper, and sHyper groups than in the NC group (P < 0.01). In addition, the number of rats crossing the virtual platform was significantly lower in the Hypo, Hyper, and sHyper groups than in the NC group (P < 0.01). Compared with the NC group, all four groups had significantly lower residence time in the target quadrant (P < 0.05). Beclin-1 and LC3-II protein expression in hippocampal tissues was significantly higher in the Hyper and sHyper groups than in the NC group (P < 0.01). Beclin-1 and LC3-II protein expression in hippocampal tissues did not significantly differ between the sHypo group and NC group (P > 0.05).

Conclusions: Subclinical thyroid dysfunction in rats might lead to cognitive impairment. Subclinical hyperthyroidism might be associated with excessive activation of autophagy and hippocampal neuron damage and necrosis.

Download full-text PDF

Source
http://dx.doi.org/10.1272/jnms.JNMS.2023_90-506DOI Listing

Publication Analysis

Top Keywords

subclinical hyperthyroidism
12
hyper shyper
12
shyper groups
12
groups group
12
group 001
12
subclinical thyroid
8
thyroid dysfunction
8
cognitive impairment
8
rats role
8
role autophagy
8

Similar Publications

Background: Thyroid dysfunction commonly coexists with type 2 diabetes mellitus (T2DM), compounding metabolic derangements and increasing the risk of complications. Despite its clinical significance, the prevalence and spectrum of thyroid dysfunction among South Asian patients with T2DM remain incompletely characterized. This study aimed to determine the frequency and types of thyroid dysfunction in patients with T2DM and to examine its associations with demographic characteristics, glycemic control, metabolic parameters, and microvascular complications.

View Article and Find Full Text PDF

Background: This study investigated the association between vitamin D status and thyroid function in 1,805 adults with type 2 diabetes mellitus (T2DM) treated at a tertiary hospital between 2018 and 2024. We analyzed demographic, metabolic, and thyroid function parameters to determine whether vitamin D levels influence thyroid dysfunction in this population.

Methods: Plasma 25-hydroxyvitamin D, thyroid hormones (FT3, FT4, TSH), and autoantibodies (TPOAb, TGAb, TRAb) were measured using electrochemiluminescence.

View Article and Find Full Text PDF

Objectives: This study retrospectively evaluated long-term clinical and biochemical findings in children and adolescents diagnosed with Hashimoto thyroiditis (HT).

Methods: A total of 233 patients aged 2-18 years, diagnosed with HT and followed for at least three years, were included. Patients were classified into five subgroups based on thyroid stimulating hormone (TSH) and free thyroxine (fT4) levels at diagnosis.

View Article and Find Full Text PDF

Background: Hyperthyroidism disrupts bone metabolism, leading to increased bone turnover and potential loss of bone mineral density. Sclerostin, a key regulator of bone formation, may serve as a useful biomarker reflecting skeletal changes in thyroid dysfunction.

Objective: To evaluate serum sclerostin levels in patients with hyperthyroidism and examine their correlation with thyroid hormone parameters-free triiodothyronine (fT), free thyroxine (fT), and thyroid-stimulating hormone (TSH).

View Article and Find Full Text PDF

Subclinical hyperthyroidism.

Curr Opin Endocrinol Diabetes Obes

October 2025

Consultant in Endocrinology and Diabetes mellitus, Endocrine department, Aberdeen Royal Infirmary, Aberdeen, Scotland, UK.

Purpose Of Review: Subclinical hyperthyroidism is a clinical condition where thyroid-stimulating hormone (TSH) is below the normal range along with normal levels of circulating thyroid hormones. It is associated with cardiovascular complications such as atrial fibrillation, but the effects on other organ systems is less certain. There are areas of uncertainty in the management of this condition, which this review seeks to address by reviewing relevant literature from the last 18 months.

View Article and Find Full Text PDF